Abstrakt
Recently, two genome-wide association studies identified single nucleotide polymorphisms (SNPs) significantly associated with the treatment response to tumor necrosis factor α (TNFα) inhibitors in patients with rheumatoid arthritis (RA). We aimed to replicate these results and identify SNPs and the possible biological pathways associated with the treatment response to TNFα inhibitors.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Pharmacogenetics and Genomics |
Vol/bind | 22 |
Udgave nummer | 8 |
Sider (fra-til) | 577-89 |
Antal sider | 13 |
ISSN | 1744-6872 |
DOI | |
Status | Udgivet - 2012 |